Samuel George A. III — SEC Form 4 filings
SEC reporting owner CIK 1878732. 8 Form 4 filings on record with FilingPulse; latest filed 2026-03-06.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-02-12 to 2026-03-06. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 15,000 shares, $9,000 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 14.
- Largest priced transaction: purchase of 15,000 shares @ $0.60 ($9,000) in Lineage Cell Therapeutics, Inc., filed 2024-11-26.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Lineage Cell Therapeutics, Inc. (LCTX) | General Counsel and Secretary | 8 | 1 leg · 15,000 sh · $9,000 | — | 14 |
Form 4 filings — Samuel George A. III
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-03-06 | 4 | Lineage Cell Therapeutics, Inc. (LCTX) | Grant/award (A): 900,000 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | Lineage Cell Therapeutics, Inc. (LCTX) | Option exercise (M): 6,075 · Tax withholding (F): 2,502 @ $1.80 · Option exercise (M): 6,075 (derivative) @ $0 | EDGAR |
| 2025-12-19 | 4 | Lineage Cell Therapeutics, Inc. (LCTX) | Grant/award (A): 1,735 · Tax withholding (F): 65 @ $1.68 | EDGAR |
| 2025-03-12 | 4 | Lineage Cell Therapeutics, Inc. (LCTX) | Grant/award (A): 750,000 (derivative) @ $0 | EDGAR |
| 2025-02-12 | 4 | Lineage Cell Therapeutics, Inc. (LCTX) | Option exercise (M): 6,076 · Tax withholding (F): 2,440 @ $0.65 · Option exercise (M): 6,076 (derivative) @ $0 | EDGAR |
| 2024-11-26 | 4 | Lineage Cell Therapeutics, Inc. (LCTX) | Purchase (P): 15,000 @ $0.60 | EDGAR |
| 2024-03-08 | 4 | Lineage Cell Therapeutics, Inc. (LCTX) | Grant/award (A): 650,000 (derivative) @ $0 | EDGAR |
| 2024-02-12 | 4 | Lineage Cell Therapeutics, Inc. (LCTX) | Option exercise (M): 6,076 · Tax withholding (F): 2,490 @ $1.08 · Option exercise (M): 6,076 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1878732 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →